2.Augmentation Strategies for the Treatment of Schizophrenia.
Journal of the Korean Society of Biological Psychiatry 1998;5(2):149-154
Antipsychotic drugs(APDs) have been effective to alleviate psychotic symptoms of schizophrenia. However, some schizophrenic patients do not respond to APDs. In addition to psychotic symptoms of schizophrenia, negative symptoms, excitement, violence, agitation, depression, and disorganization are frequently noted in patients with schizophrenia. Though APDs are the first line drugs for these symptoms, other drugs than APDs to augment the effects of APDs are efficacious for the treatment of these symptoms. Such augmenting drugs include benzodiazepines, anticonvulsants, antidepressants, lithium, and electroconvulsive therapy. These augmentation strategies can boost the effects of APDs or decrease the requirements of APDs, and consequently decrease the chance of the occurrence of side effects of APDs. Augmenting strategies are revewed for each class of drugs or treatment modality.
Anticonvulsants
;
Antidepressive Agents
;
Antipsychotic Agents
;
Benzodiazepines
;
Depression
;
Dihydroergotamine
;
Electroconvulsive Therapy
;
Humans
;
Lithium
;
Schizophrenia*
;
Violence
3.Psychoneuroimmunology: stress, depression, schizophrenia and the immune system.
Journal of Korean Neuropsychiatric Association 1992;31(5):825-836
No abstract available.
Depression*
;
Immune System*
;
Psychoneuroimmunology*
;
Schizophrenia*
4.Aeromedical analysis of flying restriction in aircrews, ROKAF.
Ki Young CHUNG ; Byoung Ok PARK
Korean Journal of Aerospace and Environmental Medicine 1993;3(1):89-97
No abstract available.
Diptera*
5.A study of relationship between defense styles and clinical symptoms II.
Journal of Korean Neuropsychiatric Association 1991;30(2):385-393
No abstract available.
6.Portal hypertension in children.
Journal of the Korean Pediatric Society 1992;35(11):1528-1536
No abstract available.
Child*
;
Humans
;
Hypertension, Portal*
7.Plasma Fibronectin Levels in Patients with Psoriasis.
Ki Young SUNG ; Sang Lip CHUNG
Korean Journal of Dermatology 1989;27(5):495-501
Fibronectin(FN) is a physiologic glycoprotein presenton cell surface and in connective tissue, extracellular matrix and plasma. Increased plasma FN levels have been reported in the patients with psoriasis, connective tissue disease, internal malignancy, squamous cell carcinoma and basal cell carcinoma. The author investigated the plasma FN levels in 30 patients (males 13, female 17) with psoriasis and 23 healthy subjects (male 13, female 10) by gelatin sepharose 4B affinity chromatography and Laurells rocket immunoelectrophoresis method. The results were as follows : Plasrna JN levels were 450.4+/-80.3pg/ml in the patients with psoriasis and 334.0-51.3pg/ml in healthy subjects. There was no relationship between age graups and sex. Plasrna FN levels in the patients with psoriasis were higher than those of healthy subjects(p<0.001). There was no relationship between the levels of plasma FN and clinical severity of psoriasis.
Carcinoma, Basal Cell
;
Carcinoma, Squamous Cell
;
Chromatography, Affinity
;
Connective Tissue
;
Connective Tissue Diseases
;
Extracellular Matrix
;
Female
;
Fibronectins*
;
Gelatin
;
Glycoproteins
;
Humans
;
Immunoelectrophoresis
;
Plasma*
;
Psoriasis*
;
Sepharose
8.Posttraumatic stress disorder and thyroid function.
Sung Deok PARK ; Moon Yong CHUNG ; Young Ki CHUNG
Journal of Korean Neuropsychiatric Association 1992;31(1):68-74
No abstract available.
Stress Disorders, Post-Traumatic*
;
Thyroid Gland*
9.The abnormalities of immune function ib schizophrenics(III).
Oh Young KWON ; Ki Seok HAN ; Young Cho CHUNG
Journal of Korean Neuropsychiatric Association 1993;32(6):998-1005
No abstract available.
10.A study of voice change after operation in unilateral vocal palsy.
Ki Hwan HONG ; Kil Yang CHUNG ; Mi Chung KIM ; Young Ki KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(6):761-769
No abstract available.
Paralysis*
;
Voice*